Joffe, Steven http://orcid.org/0000-0002-0667-7384
Conti, Rena M.
Contreras, Jorge L.
Largent, Emily A.
Lynch, Holly Fernandez
Mitchell, David
Sachs, Rachel E.
Whelan, Allison M.
McCoy, Matthew S.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (5UL1TR001878, 5UL1TR001878, 5UL1TR001878, 5UL1TR001878, 5UL1TR001878, 5UL1TR001878, 5UL1TR001878, 5UL1TR001878, 5UL1TR001878)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
Article History
Received: 7 January 2023
Revised: 4 February 2023
Accepted: 21 February 2023
First Online: 8 November 2023
Competing interests
: SJ reports receiving research funding from Pfizer through the University of Pennsylvania until May 2020 and is a member of a Data and Safety Monitoring Board for CSL Behring. DM is a patient with incurable blood cancer. He is Founder of Patients for Affordable Drugs (P4AD), a not-for-profit organization, for which he serves as an unpaid volunteer. P4AD does not accept funding from any organizations that profit from development or distribution of prescription drugs. RES reports receiving grant funding and personal fees from the Institute for Clinical and Economic Review, the National Academy for State Health Policy, and West Health. HFL reports research funding from Arnold Ventures and consulting with the Robert Wood Johnson Foundation outside the present work. RMC, JLC, EAL, MSM, and AMW have no financial relationships to report.
: No ethical approval was required as this research did not involve human or animal subjects.